Journal Article

SARS-CoV-2 Viremia Precedes an IL6 Response in Severe COVID-19 Patients: Results of a Longitudinal Prospective Cohort

Quicios, Begoña, Arévalo Román, Cristina, Arribas, David, Muñoz-Calleja, Cecilia, Cardeñoso, Laura, de la Cámara, Rafael, Marcos, Celeste, Suárez Fernández, Carmen, Patiño, Pablo, Roy-Vallejo, Emilia, Ávalos, Elena, Triguero-Martínez, Ana, Uriarte, Miren, García Castillo, Elena, García-Vicuña, Rosario, Fernández-Ruiz, Elena, Sanz-García, Ancor, Ortiz, Javier, Zurita, Nelly, Iturrate, Isabel, Ancochea, Julio, Fontán García-Rodrigo, Leticia, Villa, Almudena, Trigueros, Marina, González, Begoña, Sánchez-Azofra, Ana, Méndez, Rosa, Martín-Ramírez, Alexandra, Galván-Román, José María, Chicot Llano, Marta, González-Álvaro, Isidoro, Rodríguez-Serrano, Diego A., Barrios, Ana, Rodríguez-García, Sebastián C., Álvarez Rodríguez, Jesús, Hernando, Julia, Ciudad Sañudo, Marianela

2022

Overview

BackgroundInterleukin 6 (IL6) levels and SARS-CoV-2 viremia have been correlated with COVID-19 severity. The association over time between them has not been assessed in a prospective cohort. Our aim was to evaluate the relationship between SARS-CoV-2 viremia and time evolution of IL6 levels in a COVID-19 prospective cohort.MethodsSecondary analysis from a prospective cohort including COVID-19 hospitalized patients from Hospital Universitario La Princesa between November 2020 and January 2021. Serial plasma samples were collected from admission until discharge. Viral load was quantified by Real-Time Polymerase Chain Reaction and IL6 levels with an enzyme immunoassay. To represent the evolution over time of both variables we used the graphic command twoway of Stata.ResultsA total of 57 patients were recruited, with median age of 63 years (IQR [53–81]), 61.4% male and 68.4% Caucasian. The peak of viremia appeared shortly after symptom onset in patients with persistent viremia (more than 1 sample with > 1.3 log10 copies/ml) and also in those with at least one IL6 > 30 pg/ml, followed by a progressive increase in IL6 around 10 days later. Persistent viremia in the first week of hospitalization was associated with higher levels of IL6. Both IL6 and SARS-CoV-2 viral load were higher in males, with a quicker increase with age.ConclusionIn those patients with worse outcomes, an early peak of SARS-CoV-2 viral load precedes an increase in IL6 levels. Monitoring SARS-CoV-2 viral load during the first week after symptom onset may be helpful to predict disease severity in COVID-19 patients.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Biomarkers / COVID-19 / Cytokine storm / Hospitalization / interleukin 6 (IL-6) / Medicine / Patients / prognosis / Sample size / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / Software / Variables / viremia